SKI Market

Indian Indices

Nifty

25,879.15 3.35
(0.01%)

Sensex

84,562.78 84.11
( 0.10%)

Bank Nifty

58,381.95 107.30
( 0.18%)

Nifty IT

36,679.50 -175.90
( -0.48%)

Global Indices

Nasdaq

47,468.90 -806.92
(-1.67%)

Dow Jones

6,758.27 -113.65
(-1.65%)

Hang Seng

50,333.56 -948.27
(-1.85%)

Nikkei 225

9,816.37 -95.05
(-0.96%)

Forex

USD-INR

88.59 -0.09
(-0.10%)

EUR-INR

102.60 0.08
(0.08%)

GBP-INR

116.32 -0.42
(-0.36%)

JPY-INR

0.57 0.00
(-0.52%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Bharat Immunological & Biological Corporation Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524663

INE994B01014

-7.5352246

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

88.39

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)	Mar 2018 ( Cr)
Sales Turnover	44.61	78.39	85.33	66.84	83.65	34.80
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	44.61	78.39	85.33	66.84	83.65	34.80
Other Income	2.80	1.10	1.68	1.18	4.22	1.39
Stock Adjustments	-5.95	-0.44	-20.15	12.99	13.55	0.00
Total Income	41.46	79.05	66.86	81.01	101.42	36.19
EXPENDITURE :
Raw Materials	35.71	64.93	67.74	74.30	92.79	26.97
Power & Fuel Cost	1.35	1.69	1.55	1.85	1.74	1.24
Employee Cost	15.32	13.85	14.44	11.37	9.78	10.31
Other Manufacturing Expenses	1.16	1.39	1.22	1.53	1.17	3.23
Selling & Administrative Expenses	1.05	0.73	0.60	0.65	0.45	0.96
Miscellaneous Expenses	2.53	0.33	0.49	0.53	0.59	0.02
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	57.12	82.92	86.05	90.22	106.52	42.72
Operating Profit	-15.66	-3.87	-19.18	-9.22	-5.10	-6.54
Interest	7.05	5.60	4.79	4.75	2.00	1.01
Gross Profit	-22.71	-9.47	-23.97	-13.97	-7.10	-7.55
Depreciation	0.15	0.21	0.24	0.24	0.28	0.41
Profit Before Tax	-22.86	-9.68	-24.21	-14.21	-7.38	-7.96
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-5.79	-0.93	-6.10	-3.99	-1.58	-3.70
Reported Net Profit	-17.06	-8.75	-18.11	-10.21	-5.79	-4.26
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	-17.06	-8.75	-18.11	-10.21	-5.79	-4.26
Adjustment below Net Profit	0.00	0.00	0.00	0.01	-1.02	0.01
P & L Balance brought forward	-49.57	-40.82	-22.71	-12.50	-5.69	-1.43
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-66.63	-49.57	-40.82	-22.71	-12.50	-5.69
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-3.95	-2.03	-4.19	-2.36	-1.34	0.00
Earnings Per Share(Adj)-Unit Curr	-3.95	-2.03	-4.19	-2.36	-1.34	0.00
Book Value-Unit Curr	-5.43	-1.48	0.55	4.74	7.10	8.68
Book Value(Adj)-Unit Curr	-5.43	-1.48	0.55	4.74	7.10	8.68

25,879.15 3.35 (0.01%)

84,562.78 84.11 ( 0.10%)

58,381.95 107.30 ( 0.18%)

36,679.50 -175.90 ( -0.48%)

47,468.90 -806.92 (-1.67%)

6,758.27 -113.65 (-1.65%)

50,333.56 -948.27 (-1.85%)

9,816.37 -95.05 (-0.96%)

88.59 -0.09 (-0.10%)

102.60 0.08 (0.08%)

116.32 -0.42 (-0.36%)

0.57 0.00 (-0.52%)